Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
  • C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
  • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
  • C12N1/20—Bacteria; Culture media therefor
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1048—Glycosyltransferases (2.4)
  • C12N9/1051—Hexosyltransferases (2.4.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1048—Glycosyltransferases (2.4)
  • C12N9/1077—Pentosyltransferases (2.4.2)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/14—Hydrolases (3)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P13/00—Preparation of nitrogen-containing organic compounds
  • C12P13/04—Alpha- or beta- amino acids
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P13/00—Preparation of nitrogen-containing organic compounds
  • C12P13/04—Alpha- or beta- amino acids
  • C12P13/14—Glutamic acid; Glutamine
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y204/00—Glycosyltransferases (2.4)
  • C12Y204/02—Pentosyltransferases (2.4.2)
  • C12Y204/02017—ATP phosphoribosyltransferase (2.4.2.17)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
  • C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
  • C12Y306/01031—Phosphoribosyl-ATP diphosphatase (3.6.1.31)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N2830/00—Vector systems having a special element relevant for transcription
  • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria

Definitions

• the present application relates to a microorganism having an increased glycine production capacity and a fermentation composition production method using the same, and more particularly, a microorganism belonging to the genus Corynebacterium in which a mutation is introduced into HisG to increase the glycine production capacity, and glycine and glutamic acid using the same. It relates to a method for producing a fermentation composition, and to the fermentation composition.
• L-amino acid is a basic structural unit of protein, and is used as an important material for pharmaceutical raw materials, food additives, animal feed, nutrition, pesticides, and fungicides.
• L-glutamic acid is a representative amino acid produced by fermentation, and has one of the unique amino acids, which is widely used not only in the food field but also in the pharmaceutical field and other animal feed fields.
• glycine is mainly used as a seasoning in the food industry to sweeten, and used with natural seasoning to enhance the taste. Furthermore, it is used also for antioxidant activity, buffering effect, etc., and it is used for sap, antacid, comprehensive amino acid preparation, and nutritional supplement in medicine.
• the present inventors have tried to develop a method capable of simultaneously producing several amino acids, and as a result, in the glutamic acid producing strain, when the HisG activity is enhanced compared to the parent strain, it is possible to improve the glycine producing ability while maintaining the producing ability of glutamic acid. Confirmed to complete the present application.
• One object of the present application is to provide a microorganism of the genus Corynebacterium with increased glycine production capacity, enhanced activity of ATP phosphoribosyltransferase (HTP).
• HTP ATP phosphoribosyltransferase
• Another object of the present application is to provide a method for producing a fermentation composition comprising glycine and glutamic acid, comprising the step of culturing the microorganism of the genus Corynebacterium in the medium.
• Another object of the present application is to provide a fermentation composition prepared by the above method.
• HisG mutation of the present application is introduced into a microorganism can be produced simultaneously in the production of glutamic acid and glycine may be useful for amino acid production.
• glutamic acid and glycine may be useful for amino acid production.
• by adjusting the amount of glutamic acid and the amount of glycine in the fermented product to improve the taste and palatability of the fermented product can be applied to the fermentation broth and seasoning material products using the same.
• one embodiment of the present application provides a microorganism of the genus Corynebacterium with increased glycine production capacity, enhanced activity of ATP phosphoribosyltransferase (HTP).
• HTP ATP phosphoribosyltransferase
• the microorganism of the genus Corynebacterium with increased glycine production capacity including ATP phosphoribosyltransferase (HISS), in which the 233th amino acid of the amino acid sequence represented by SEQ ID NO: 4 is substituted with histidine (H) can be provided.
• HISS ATP phosphoribosyltransferase
• SEQ ID NO: 4 includes the ATP phosphoribosyltransferase (HTP) in which the 233th amino acid of the amino acid sequence is substituted with histidine (H) and the 235th amino acid is substituted with glutamine (Q).
• HTP ATP phosphoribosyltransferase
• ATP phosphoribosyltransferase is also named “HisG” and means an enzyme involved in the histidine synthesis pathway.
• the histidine synthesis pathway consists of a total of nine enzymes (HisG-HisE-HisI-HisA-HisH-HisB-HisC-HisN-HisD)
• the HisG constitutes one step.
• HisG is involved in histidine production, but its association with glycine production is not known and was first identified by the present inventors. More specifically, glycine production is increased through enhanced HisG activity, in particular, HisG is subject to feedback suppression by the product histidine, and the present application introduces a variation in releasing histidine feedback suppression, thereby increasing glycine production and The effect of maintaining the amount of glutamic acid produced was first identified by the present inventors.
• enhancing the activity of HisG means that the activity of HisG enzyme is increased than the intrinsic activity, which is the active state of the enzyme that the microorganism of Corynebacteria has in its natural state.
• methods for enhancing the activity of HisG include: i) a method of additionally inserting a polynucleotide containing a base sequence encoding HisG into a chromosome or a polynucleotide comprising a base sequence encoding HisG into a vector system A method of increasing the copy number of the nucleotide sequence encoding the enzyme, and the like, ii) a method of enhancing a promoter of hisG gene, for example, a method of replacing with a strong promoter, or a method of introducing a mutation into a promoter. And iii) a method of mutating the enzyme into a highly active enzyme by gene mutation.
• glycine which is the 233th amino acid of the HisG amino acid sequence represented by SEQ ID NO: 4 is substituted with histidine, or 233th amino acid of the HisG amino acid sequence represented by SEQ ID NO: 4, the glycine is substituted with histidine and the 235th amino acid Phosphorus threonine may be substituted with glutamine.
• the microorganism of the genus Corynebacterium containing the above-described mutated HisG can significantly increase glycine producing ability while maintaining little effect on the production ability of glutamic acid.
• the increase in glycine production capacity may be increased compared to the microorganisms having HisG that does not include the modification of the present application, ie, the substitution.
• the promoter of HisG enzyme may be mutated to a strong promoter relative to the intrinsic promoter through mutation or substitution.
• An improved promoter or heterologous promoter having a base substitution mutation may be linked to the promoter of the endogenous enzyme.
• the heterologous promoter include a cj7 promoter, a lysCP1 promoter, an EF-Tu promoter, a groEL promoter, an aAA promoter, and an aceB promoter. It is not limited.
• the promoter sequence of the hisEG gene may enhance hisG enzyme activity through hisG overexpression due to mutation or substitution. More specifically, the promoter sequence of the hisEG gene is mutated from SEQ ID NO: 1 to the 53rd and 55th nucleotides of the polynucleotide sequence by T, or the 53rd and 55th nucleotides of the polynucleotide sequence by T to the 60th nucleotide. By substituting, it is possible to enhance the activity of HisG enzyme with a stronger promoter as compared to the intrinsic promoter. Promoter sequence study of Corynebacterium glutamicum (Microb Biotechnol.
• RNA-seq transcriptional start points
• the location can be determined.
• TSPs transcriptional start points
• RNA-seq RNA sequencing
• the location can be determined.
• the RNA sequence of the histone gene of Corynebacterium glutamicum wild type ATCC13869 was confirmed to identify the promoter sequence of the hisEG gene and to induce hisEG overexpression through native promoter modification.
• One of the methods of intrinsic promoter modification is to approach the consensus sequence through mutation of the -35 and -10 region sequences of the promoter of Corynebacterium glutamicum.
• TATA box sequence of the -10 region from the promoter sequence of the hisEG gene is shifted closer to the consensus sequence, it can be transformed into a strong promoter compared to the intrinsic promoter.
• the ATP phosphoribosyltransferase included in the microorganism of the genus Corynebacterium may be composed of the amino acid sequence of SEQ ID NO: 5, or the ATP phosphoribosyltransferase is composed of the amino acid sequence of SEQ ID NO: 6 Can be.
• amino acid sequence of the present application can be modified by conventionally known mutagenesis methods, such as direct evolution and site-directed mutagenesis.
• the ATP phosphoribosyltransferase is at least 60%, specifically at least 70%, more specifically at least 80%, even more specifically 83% relative to the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6 HisG comprising an amino acid sequence having at least 84%, at least 88%, at least 90%, at least 93%, at least 95%, or at least 97% homology. If the sequence having homology with the sequence and having an amino acid sequence having a biological activity substantially the same as or corresponding to the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6, when some sequences have an amino acid sequence deleted, modified, substituted or added It is obvious that also included in the scope of the present application.
• glutamic acid is a kind of amino acids are classified as non-essential amino acids. It is known as the most common excitatory neurotransmitter in the central nervous system, and because it is umami, its monosodium glutamate (MSG) has been widely used as a seasoning. Typically produced through fermentation of microorganisms that produce glutamic acid.
• glycine is also an amino acid of sweet colorless crystals, also referred to as glycine. It is mainly used as food seasoning, and in medicine, it is also used as sap, antacid, comprehensive amino acid, and nutritional supplement.
• the monochloroacetic acid method, the Strecker (Strecker) method, etc. are prepared through industrial synthesis methods, the synthesis method is produced by mixing the D- and L-type amino acids, there is an inconvenience that requires optical splitting. Therefore, there is a need to prepare glycine by fermentation which has various advantages such as mild reaction conditions, mass production in a short time, environmentally friendly processes, and biodegradable production materials.
• homology refers to the degree of agreement with a given amino acid sequence or nucleotide sequence and can be expressed as a percentage.
• homologous sequences thereof having the same or similar activity as a given amino acid sequence or nucleotide sequence are designated as "% homology”.
• Homology to the amino acid sequence or nucleotide sequence is described, for example, in the algorithm BLAST by Karlin and Altschul, Pro. Natl. Acad. Sci. USA, 90, 5873 (1993)] or FASTA by Pearson (Methods Enzymol., 183, 63, 1990). Based on this algorithm BLAST, a program called BLASTN or BLASTX has been developed (see http://www.ncbi.nlm.nih.gov).
• stringent conditions is meant a condition that enables specific hybridization between polynucleotides. Such conditions are described specifically in the literature (eg, J. Sambrook et al., Homology). For example, genes with high homology, 60% or more, specifically 90% or more, more specifically 95% or more, more specifically 97% or more, particularly specifically 99% or more homologous genes 60 ° C., 1 ⁇ SSC, 0.1% SDS, specifically 60 ° C., 0.1 ⁇ SSC, 0.1, which is a condition for hybridizing with each other and not having homologous genes with each other, or washing conditions for normal Southern hybridization.
• Hybridization requires that two nucleotides have complementary sequences, although mismatch between bases is possible depending on the stringency of the hybridization.
• the term "complementary" is used to describe the relationship between nucleotide bases that can hybridize with each other. For example, with respect to DNA, adenosine is complementary to thymine and cytosine is complementary to guanine.
• the present application may also include isolated polynucleotide fragments that are complementary to the entire sequence as well as substantially similar polynucleotide sequences.
• polynucleotides having homology can be detected using hybridization conditions including hybridization steps at Tm values of 55 ° C. and using the conditions described above.
• the Tm value may be 60 ° C, 63 ° C or 65 ° C, but is not limited thereto and may be appropriately adjusted by those skilled in the art according to the purpose.
• Appropriate stringency to hybridize polynucleotides depends on the length and degree of complementarity of the polynucleotides and variables are well known in the art (see Sambrook et al., Supra, 9.50-9.51, 11.7-11.8).
• microorganism includes both wild-type microorganisms and microorganisms in which natural or artificial genetic modification has occurred, and a certain mechanism is weakened due to the insertion of an external gene or an enhanced or weakened activity of an endogenous gene.
• the concept includes both microorganisms that have been enhanced or fortified.
• the microorganism may include the ATP phosphoribosyltransferase.
• the ATP phosphoribosyltransferase may be introduced into the microorganism by transformation through a vector, but is not limited thereto.
• the HisG can be expressed, the microorganism is irrelevant to whether the gene encoding HisG is located on or outside the chromosome.
• vector in the present application is an artificial DNA molecule that carries a genetic material to be able to express a gene of interest in a suitable host, it may mean a DNA preparation comprising the nucleotide sequence of the gene encoding the HisG.
• the vector used in the present application is not particularly limited as long as it can be expressed in the host cell, and any vector known in the art may be used to transform the host cell.
• Examples of commonly used vectors include natural or recombinant plasmids, cosmids, viruses and bacteriophages.
• pWE15, M13, ⁇ LB3, ⁇ BL4, ⁇ IXII, ⁇ ASHII, ⁇ APII, ⁇ t10, ⁇ t11, Charon4A, Charon21A, etc. can be used as a phage vector or cosmid vector, and pBR, pUC, and pBluescriptII systems as plasmid vectors.
• pGEM-based, pTZ-based, pCL-based and pET-based and the like can be used.
• a polynucleotide encoding HisG of the present application may be introduced into a chromosome through a vector for chromosome insertion in a host cell.
• a vector for chromosome insertion in a host cell.
• pECCG117, pDZ, pACYC177, pACYC184, pCL, pUC19, pBR322, pMW118, pCC1BAC, pCES208, pXMJ19 vectors and the like can be used, but are not limited thereto.
• the insertion of the polynucleotide into the chromosome can be by any method known in the art, for example by homologous recombination.
• the vector of the present application may be inserted into a chromosome by causing homologous recombination
• the vector may further include a selection marker for confirming whether the chromosome is inserted.
• Selection markers are used to screen for cells transformed with a vector, i.e. to confirm the insertion of polynucleotides, and to provide selectable phenotypes such as drug resistance, nutritional requirements, resistance to cytotoxic agents or expression of surface proteins. Markers can be used. In an environment in which a selective agent is treated, only cells expressing a selection marker survive or exhibit different expression traits, so that transformed cells can be selected.
• transformation in the present application means to introduce a vector comprising the gene encoding the polynucleotide or HisG into the host cell, such that the gene and HisG can be expressed in the host cell. Furthermore, as long as the gene of interest can be expressed in the host cell, the transformed gene can include both cases, whether located on or outside the chromosome of the host cell.
• the transformation method includes all methods of introducing the gene into the cell, and may be performed by selecting a suitable standard technique as known in the art depending on the host cell. For example, electroporation, calcium phosphate (CaPO 4 ) precipitation, calcium chloride (CaCl 2 ) precipitation, microinjection, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method, and Lithium acetate-DMSO method and the like, but is not limited thereto.
• a suitable standard technique as known in the art depending on the host cell. For example, electroporation, calcium phosphate (CaPO 4 ) precipitation, calcium chloride (CaCl 2 ) precipitation, microinjection, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method, and Lithium acetate-DMSO method and the like, but is not limited thereto.
• the microorganism may be included without limitation as long as the microorganism capable of introducing HisG of the present application to increase glycine production ability.
• the microorganism may be a microorganism of the genus Corynebacterium, and more specifically, Corynebacterium glutamicum ( Coynebacterium) glutamicum ) or Corynebacterium plavum flavum ), and most specifically Corynebacterium glutamicum, but is not limited thereto.
• Another aspect of the present application provides a method for preparing a fermentation composition comprising glycine and glutamic acid, comprising culturing the microorganism of the genus Corynebacterium in a medium.
• Another aspect of the present application provides a fermentation composition prepared by the above method.
• the fermentation composition may be an increased content of glycine.
• the microorganism is as described above.
• the term "culture” refers to the growth of microorganisms under appropriately artificially controlled environmental conditions.
• a method of producing a target substance using the microorganism may be performed using a method well known in the art.
• the culture may be continuously cultured in a batch process, an injection batch or a repeated fed batch process, but is not limited thereto.
• the medium used for cultivation must meet the requirements of the particular strain in an appropriate manner.
• Culture media for Corynebacterium strains are known (eg, Manual of Methods for General Bacteriology by the American Society for Bacteriology, Washington D.C., USA, 1981).
• Sugar sources that may be used in the medium include glucose and saccharose, lactose, fructose, maltose, starch, sugars and carbohydrates such as cellulose, soybean oil, sunflower oil, castor oil, coconut oil and the like, palmitic acid, stearic acid Fatty acids such as linoleic acid, alcohols such as glycerol, ethanol, and organic acids such as acetic acid. These materials can be used individually or as a mixture, but are not limited thereto.
• Nitrogen sources that can be used include peptone, yeast extract, gravy, malt extract, corn steep liquor, soybean wheat and urea or inorganic compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate. Nitrogen sources can also be used individually or as a mixture, but are not limited thereto.
• Personnel that can be used can include salts containing potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium.
• the culture medium may contain a metal salt such as magnesium sulfate or iron sulfate required for growth.
• essential growth substances such as amino acids and vitamins can be used.
• suitable precursors to the culture medium may be used. The above-mentioned raw materials may be added batchwise or continuously in a manner appropriate to the culture during the culturing process.
• the pH of the culture can be adjusted by using a basic compound such as sodium hydroxide, potassium hydroxide, ammonia or an acid compound such as phosphoric acid or sulfuric acid in an appropriate manner.
• a basic compound such as sodium hydroxide, potassium hydroxide, ammonia or an acid compound such as phosphoric acid or sulfuric acid in an appropriate manner.
• antifoaming agents such as fatty acid polyglycol esters can be used to inhibit bubble generation.
• Oxygen or an oxygen-containing gas eg, air may be injected into the culture to maintain aerobic conditions.
• the temperature of the culture can usually be 20 ° C to 45 ° C, specifically 25 ° C to 40 ° C. Incubation time may be continued until the desired amount of the desired material is obtained, but may specifically be 10 to 160 hours.
• Recovery of the desired material from the culture (medium) can be recovered separately by conventional methods known in the art.
• methods such as centrifugation, filtration, chromatography, and crystallization may be used.
• the supernatant obtained by removing the biomass by centrifuging the culture at low speed may be separated by ion exchange chromatography, but is not limited thereto.
• cell separation and filtration from the culture (medium) may be performed and the desired material may be recovered without a separate purification process.
• the recovery step may further comprise a purification process.
• the fermentation composition in the present application means a composition obtained by culturing the microorganism of the present application.
• the fermentation composition may include a liquid or powder composition obtained after culturing the microorganism, and after an appropriate post-treatment process.
• a suitable post-treatment step may include, for example, a culture step, a cell removal step, a concentration step, a filtration step, and a carrier mixing step of the microorganism, and may further include a drying step.
• the post-treatment process may not include a purification process.
• the fermentation composition may have an optimal taste by culturing the microorganism of the present application to include a composition with an increased content of glycine while maintaining a certain level of glutamic acid content.
• the fermentation composition does not exclude seasoning products (eg, broth powder products, snack seasoning products, etc.) containing the composition in the liquid or powder form.
• seasoning products eg, broth powder products, snack seasoning products, etc.
• the fermentation composition as long as it includes a composition obtained by culturing the microorganism of the present application, and the case of further mixing the material obtained by the non-fermentation process and / or another material obtained by the non-natural process Do not exclude
• HisE and HisG genes are composed of operon and these genes are involved in histidine biosynthesis pathway.
• HisG is subject to feedback suppression by the product histidine
• the 233th glycine (Gly / G) of the HisG amino acid sequence represented by SEQ ID NO: 4 is replaced with histidine (His / H), and the 233th and 235th glycine (Gly / G) and threonine (Thr / T) Gene replacement vectors were prepared for substitution with histidine (His / H) and glutamine (Gln / Q).
• Gene fragments for constructing each substitution vector was obtained by PCR with ATCC13869 genomic DNA as a template. Based on the information on the Corynebacterium glutamicum (ATCC13869) gene and the surrounding nucleotide sequence registered in the National Institutes of Health (NIH GenBank), each primer was prepared.
• PCR conditions for the production of HisEG promoter substitution vector were denatured at 95 ° C. for 5 minutes, followed by 30 times of 95 ° C. denaturation, 55 ° C. 30 seconds annealing, 72 ° C. 1 minute polymerization, and polymerization at 72 ° C. for 5 minutes.
• the reaction was carried out. More specifically, 500bp polynucleotides amplified using the SEQ ID NOS: 7 and 8 primers and 500bp polynucleotides amplified using the primers SEQ ID NOs: 9 and 10 were obtained.
• the two gene fragments were linked to the pDZ vector (Korean Patent No. 10-0924065 and International Publication No.
• Gene replacement vectors were constructed to replace H, H, and Q amino acids 233, 233 and 235 of the HisG amino acid sequence, respectively. Specifically, PCR conditions were denatured for 5 minutes at 95 °C, 95 °C 30 seconds denaturation, 55 °C 30 seconds annealing, 72 °C 1 min polymerization was repeated 30 times, and then polymerization was carried out at 72 °C 5 minutes. 722 bp polynucleotides amplified using the primers of SEQ ID NOs: 13 and 14 and 798 bp polynucleotides amplified using the primers of SEQ ID NOs: 15 and 16 were obtained. The two gene fragments obtained were linked to pDZ vectors (Korean Patent No.
• a strain prepared by transformation (Appl. Microbiol. Biotechnol., 1999, 52: 541-545), and a vector having a vector inserted on a chromosome by recombination of homologous sequences, 25 mg / L of kanamycin (kanamycin) It was selected from agar nutrient medium containing. The selected primary strains were subjected to second cross-over again, and the strains into which the target mutations were introduced were selected. Variation (substitution) of the final transformed strain was confirmed by sequencing after PCR using primer pairs of SEQ ID NOs: 7 and 10 and primer pairs of SEQ ID NOs: 13 and 16, respectively.
• the selected strains KFCC11074_Pro (2mt) _hisEG, KFCC11074_Pro (3mt) _hisEG, KFCC11074_hisG (G233H) and KFCC11074_hisG (G233H / T235Q) were plated on nutrient medium and incubated at 30 ° C for 16 hours. Thereafter, 25 ml of autoclaved fermentation broth at 121 ° C. for 15 minutes was dispensed into a 250 ml shaking Erlenmeyer flask and incubated for 48 hours by inoculating strains cultured in a nutrient medium. Culture conditions were adjusted to 200 rpm, temperature 37 °C, pH 8.0.
• the nutrition medium and fermentation medium composition is as follows.
• concentrations of L-glutam produced by Corynebacterium glutamicum KFCC11074_Pro (2mt) _hisEG, KFCC11074_Pro (3mt) _hisEG, KFCC11074_hisG (G233H) and KFCC11074_hisG (G233H / T235Q) strains with the introduced mutations. was confirmed to be similar to the concentration of L-glutamic acid produced by the Corynebacterium glutamicum KFCC11074 strain without mutation.
• the concentration of glycine produced by the KFCC11074_Pro (2mt) _hisEG and KFCC11074_Pro (3mt) _hisEG and KFCC11074_hisG (G233H) strains was 33 mg / L, 44 mg / L, and 45 mg, respectively, compared to the glycine concentration produced by KFCC11074. It was confirmed that / L increased. In particular, the KFCC11074_hisG (G233H / T235Q) strain was confirmed that the glycine concentration significantly increased to 268 mg / L.
• HisD promoter substitution vectors pDZ-hisEG-pro-2mt and pDZ-hisEG-pro-3mt and HisD gene substitution vectors pDZ-hisG (G233H) and pDZ-hisG (G233H / T235Q) prepared in Example 1-1 ) were introduced into the ATCC13869 strain by the electroporation method, respectively.
• a strain prepared by transformation (Appl. Microbiol. Biotechnol., 1999, 52: 541-545), and a vector having a vector inserted on a chromosome by recombination of homologous sequences, 25 mg / L of kanamycin (kanamycin) It was selected from agar nutrient medium containing. The selected primary strains were subjected to second cross-over again, and the strains into which the target mutations were introduced were selected. Variation (substitution) of the final transformed strain was confirmed by sequencing after PCR using primer pairs of SEQ ID NOs: 7 and 10 and primer pairs of SEQ ID NOs: 13 and 16, respectively.
• Each colony was subcultured in nutrient medium and then incubated for 5 hours in fermentation medium. Then, 25% Tween40 was added to each medium at 0.4% concentration, and each colony was incubated again for 32 hours.
• L-glutamic acid g / L
• L-Glycine mg / L
• ATCC13869 13.8 117 ATCC13869_Pro (2mt) _hisEG 13.7 128 ATCC13869_Pro (3mt) _hisEG 14.0 135 ATCC13869_hisG (G233H) 13.5
• ATCC13869_hisG G233H / T235Q
• ATCC13869_Pro (2mt) _hisEG, ATCC13869_Pro (3mt) _hisEG, ATCC13869_hisG (G233H) and ATCC13869_hisG (G233H / T235Q) strains with mutations introduced into wild-type Corynebacterium glutamicum (ATCC13869) were produced.
• the concentration of L-glutamic acid was similar to that of L-glutamic acid produced by the ATCC13869 strain, but the glycine concentrations were all increased.
• ATCC13869_hisG (G233H) and ATCC13869_hisG (G233H / T235Q) strains are the strains "CA02-9216" and "CA02-9217” to the Korea Microorganism Conservation Center (KCCM), which is a depository under the Treaty of Budapest on March 00, 2019. International deposits have been given accession numbers "KCCM12458P" and "KCCM12459P".
• the present invention was to prepare a fermentation composition using a microorganism of the genus HisG activity enhanced Corynebacterium.
• the glutamic acid which is basically a well-known seasoning material, is manufactured as a main ingredient, but the fermentation strain and the fermentation process are controlled to increase by-product components of other seasoning materials in order to increase the composition of rich flavor.
• Primary seed medium 1% glucose, 1% yeast extract, 1% peptone, 0.1% ammonium sulfate, 0.25% sodium chloride, 0.15% potassium phosphate monobasic, 0.15% potassium diphosphate, primary pH Seed media were prepared.
• Secondary species 4.6% organic raw sugar with a purity of 98.5%, magnesium sulfate 0.05%, yeast extract 0.5%, potassium monophosphate 0.2%, iron sulfate 0.002%, biotin 1 mg / l, thiamine hydrochloride 2 mg / l and some
• a secondary seed medium containing an antifoaming agent and having a pH of 7.2 was prepared.
• Fermentation medium 4% organic raw sugar with a purity of 98.5%, magnesium sulfate 0.03%, yeast extract 1%, phosphoric acid 0.22%, potassium hydroxide 0.4%, biotin 0.2mg / l, thiamine hydrochloride 0.6mg / l, manganese sulfate 0.002%, sulfuric acid
• a fermentation medium containing pH 0.002%, zinc sulfate 0.002%, copper sulfate 0.0006% and some antifoaming agent and having a pH of 7.4 was prepared.
• 50 ml of the primary seed medium was dispensed into a 500 ml shaking Erlenmeyer flask and cooled by autoclaving at 121 ° C. for 20 minutes, and then inoculated with the strains at 200 rotations / minute and a temperature of 5 ° C. at 30 ° C. Shake culture was carried out for 7 hours.
• 0.25L of the secondary seed medium was prepared in a 1.5L test fermenter, cooled by autoclaving at 121 ° C. for 20 minutes, inoculated with 50 ml of the primary seed culture solution, and then rotated at 900 revolutions / minute at 31.5 ° C. Incubated for 15 hours at.
• 0.25L of the fermentation broth was prepared in a 5L test fermenter, cooled by autoclaving at 121 ° C. for 20 minutes, and then inoculated with 0.26 L of the secondary seed culture solution, and then rotated at 900 revolutions per minute at 30 to 34 ° C. Incubated at.
• the pH of the fermentation broth during incubation of the Corynebacterium glutamicum was continuously adjusted using 28% ammonia water so as to be in the range of 7.0 to 7.4.
• concentration of residual sugar was 0.5-1.5% during the cultivation, sterilized organic raw sugar was added at any time, and the culture was continued until the total sugar added was 30-34% of the fermentation broth.
• the glutamic acid production between the two strains was not significantly different.
• the content of glycine was significantly increased (0.2 g / L vs 3.2 g / L) without significant difference in glutamic acid production (64.2 g / L vs 73 g / L).

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Genetics & Genomics (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Engineering & Computer Science (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Biotechnology (AREA)
• Microbiology (AREA)
• Biomedical Technology (AREA)
• Molecular Biology (AREA)
• Medicinal Chemistry (AREA)
• Biophysics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Plant Pathology (AREA)
• Physics & Mathematics (AREA)
• Gastroenterology & Hepatology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Virology (AREA)
• Tropical Medicine & Parasitology (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Seasonings (AREA)
• Enzymes And Modification Thereof (AREA)

Priority Applications (11)

Applications Claiming Priority (2)

Publications (1)

Family

ID=68060246

Family Applications (2)

Family Applications After (1)

Country Status (13)

Families Citing this family (12)

Citations (6)

Family Cites Families (10)

• 2019
  • 2019-03-27 TW TW108110750A patent/TWI716841B/zh active
  • 2019-03-27 CN CN201980004266.4A patent/CN111433366B/zh active Active
  • 2019-03-27 BR BR112020003867-9A patent/BR112020003867B1/pt active IP Right Grant
  • 2019-03-27 KR KR1020190035199A patent/KR102137806B1/ko active Active
  • 2019-03-27 TW TW109131887A patent/TW202117002A/zh unknown
  • 2019-03-27 WO PCT/KR2019/003568 patent/WO2019190193A1/ko not_active Ceased
  • 2019-03-27 EP EP19776661.1A patent/EP3778901B1/en active Active
  • 2019-03-27 TW TW108110751A patent/TWI746953B/zh active
  • 2019-03-27 MY MYPI2020000969A patent/MY202021A/en unknown
  • 2019-03-27 AR ARP190100765A patent/AR115302A1/es unknown
  • 2019-03-27 AU AU2019243242A patent/AU2019243242B2/en active Active
  • 2019-03-27 EP EP22181523.6A patent/EP4130281A1/en active Pending
  • 2019-03-27 KR KR1020190035198A patent/KR102028554B1/ko active Active
  • 2019-03-27 CN CN201980004245.2A patent/CN111655860B/zh active Active
  • 2019-03-27 EP EP19775192.8A patent/EP3778900A4/en active Pending
  • 2019-03-27 CA CA3073177A patent/CA3073177C/en active Active
  • 2019-03-27 AR ARP190100764A patent/AR115301A1/es unknown
  • 2019-03-27 CA CA3073180A patent/CA3073180C/en active Active
  • 2019-03-27 JP JP2020512734A patent/JP7089582B2/ja active Active
  • 2019-03-27 BR BR112020003467A patent/BR112020003467B8/pt active IP Right Grant
  • 2019-03-27 WO PCT/KR2019/003565 patent/WO2019190192A1/ko not_active Ceased
  • 2019-03-27 JP JP2020512742A patent/JP7125477B2/ja active Active
  • 2019-03-27 SG SG11202001730TA patent/SG11202001730TA/en unknown
  • 2019-03-27 AU AU2019243241A patent/AU2019243241B2/en active Active
  • 2019-03-27 US US16/639,364 patent/US10961554B2/en active Active
  • 2019-03-27 SG SG11202001753TA patent/SG11202001753TA/en unknown
  • 2019-03-27 US US16/638,974 patent/US11661616B2/en active Active
• 2020
  • 2020-07-20 KR KR1020200089780A patent/KR102150041B1/ko active Active
• 2022
  • 2022-05-06 JP JP2022076489A patent/JP7607613B2/ja active Active

Patent Citations (7)

Non-Patent Citations (11)

Also Published As

Similar Documents

Legal Events